For one day, researchers, clinicians and philosophers debated the therapeutic use of psychedelics in the field of mental health. The event Psychedelic Therapy: From Evidence to Equity took place at the Champalimaud Foundation, with the presence of international speakers.
In the aftermath of the meeting, SIC Notícias talks about "an area that promises to revolutionize mental health", with proven results in the treatment of depression, anxiety and trauma. "The aim was to discuss the therapeutic use of psychedelics and reflect on the ethical, regulatory and social framework of their clinical potential," said Albino Oliveira Maia, director of the Champalimaud Foundation's Neuropsychiatry Unit, in statements to the news channel.
The event took place as part of PsyPal, a consortium funded by the European Union that is studying the use of psilocybin - a psychedelic compound found in certain mushrooms - to relieve symptoms of depression in people with serious illnesses. Since 2024, the foundation has been collaborating on a study of this substance, with the aim of implementing it in the treatment of people with Parkinson's disease, which is already happening, albeit in a test phase.
Jules Evans was another of the guest speakers. The British philosopher and researcher has dedicated himself to understanding the less explored effects of the use of psychedelics such as LSD, psilocybin, DMT or mescaline on mental health. "Psychedelics are amplifiers [...] In favorable conditions, they can lead to emotional breakthroughs and lasting positive changes. But in stressful or unsafe contexts, the experience can become overwhelming, terrifying or disorganizing," he told SIC Notícias.
Another substance discussed by experts was ketamine, whose use in this context was approved by Infarmed this year. "[...] the study we took part in showed good results: around half of the patients achieved complete resolution of symptoms after 32 weeks," Oliveira Maia said.
Among the most consensual conclusions of the symposium held on October 1st was the importance of guaranteeing the safety of these treatments through accredited professional supervision and a solid scientific basis. Responsibility and prudence are therefore key ideas shared by experts.
"Prohibition didn't work - it pushed use underground. But freedom without regulation would be reckless. We need clear safety standards, licensing for facilitators, public education and legal frameworks that recognize therapeutic and spiritual use while protecting people from abuse and exploitation," said Evans.
Read the full article here.
